Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand

(2017) Tawee Chotpitayasunondh et al.   VACCINE

Vaccines against pseudorabies virus (PrV)

(2017) C.M. Freuling et al.   VETERINARY MICROBIOLOGY

Classical swine fever vaccines—State-of-the-art

(2017) Sandra Blome et al.   VETERINARY MICROBIOLOGY

Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge

(2016) Christopher Schutta et al.   VACCINE

Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus

(2016) Walid H. Kilany et al.   PLoS One

The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur?

(2013) T.J.D. Knight-Jones et al.   PREVENTIVE VETERINARY MEDICINE

Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues

(2012) Nestor Montiel et al.   VACCINE

Development of vaccines toward the global control and eradication of foot-and-mouth disease

(2011) Luis L Rodriguez et al.   Expert Review of Vaccines

Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve

(2010) Sarah J. Cox et al.   VACCINE